417 related articles for article (PubMed ID: 8755668)
1. Functional beta3-adrenoceptor in the human heart.
Gauthier C; Tavernier G; Charpentier F; Langin D; Le Marec H
J Clin Invest; 1996 Jul; 98(2):556-62. PubMed ID: 8755668
[TBL] [Abstract][Full Text] [Related]
2. The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle.
Gauthier C; Leblais V; Kobzik L; Trochu JN; Khandoudi N; Bril A; Balligand JL; Le Marec H
J Clin Invest; 1998 Oct; 102(7):1377-84. PubMed ID: 9769330
[TBL] [Abstract][Full Text] [Related]
3. Interspecies differences in the cardiac negative inotropic effects of beta(3)-adrenoceptor agonists.
Gauthier C; Tavernier G; Trochu JN; Leblais V; Laurent K; Langin D; Escande D; Le Marec H
J Pharmacol Exp Ther; 1999 Aug; 290(2):687-93. PubMed ID: 10411579
[TBL] [Abstract][Full Text] [Related]
4. Beta3-adrenoceptor in the eel (Anguilla anguilla) heart: negative inotropy and NO-cGMP-dependent mechanism.
Imbrogno S; Angelone T; Adamo C; Pulerà E; Tota B; Cerra MC
J Exp Biol; 2006 Dec; 209(Pt 24):4966-73. PubMed ID: 17142685
[TBL] [Abstract][Full Text] [Related]
5. Endothelial beta3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization.
Dessy C; Moniotte S; Ghisdal P; Havaux X; Noirhomme P; Balligand JL
Circulation; 2004 Aug; 110(8):948-54. PubMed ID: 15302798
[TBL] [Abstract][Full Text] [Related]
6. Evidence for beta3-adrenoceptor subtypes in relaxation of the human urinary bladder detrusor: analysis by molecular biological and pharmacological methods.
Takeda M; Obara K; Mizusawa T; Tomita Y; Arai K; Tsutsui T; Hatano A; Takahashi K; Nomura S
J Pharmacol Exp Ther; 1999 Mar; 288(3):1367-73. PubMed ID: 10027879
[TBL] [Abstract][Full Text] [Related]
7. Cardiostimulant and cardiodepressant effects through overexpressed human beta2-adrenoceptors in murine heart: regional differences and functional role of beta1-adrenoceptors.
Heubach JF; Blaschke M; Harding SE; Ravens U; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):380-90. PubMed ID: 12690430
[TBL] [Abstract][Full Text] [Related]
8. Altered contractile response due to increased beta3-adrenoceptor stimulation in diabetic cardiomyopathy: the role of nitric oxide synthase 1-derived nitric oxide.
Amour J; Loyer X; Le Guen M; Mabrouk N; David JS; Camors E; Carusio N; Vivien B; Andriantsitohaina R; Heymes C; Riou B
Anesthesiology; 2007 Sep; 107(3):452-60. PubMed ID: 17721248
[TBL] [Abstract][Full Text] [Related]
9. Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta.
Trochu JN; Leblais V; Rautureau Y; Bévérelli F; Le Marec H; Berdeaux A; Gauthier C
Br J Pharmacol; 1999 Sep; 128(1):69-76. PubMed ID: 10498836
[TBL] [Abstract][Full Text] [Related]
10. The negative inotropic action of catecholamines: role of beta3-adrenoceptors.
Gauthier C; Leblais V; Moniotte S; Langin D; Balligand JL
Can J Physiol Pharmacol; 2000 Sep; 78(9):681-90. PubMed ID: 11007530
[TBL] [Abstract][Full Text] [Related]
11. Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart.
Rozec B; Erfanian M; Laurent K; Trochu JN; Gauthier C
J Am Coll Cardiol; 2009 Apr; 53(17):1532-8. PubMed ID: 19389564
[TBL] [Abstract][Full Text] [Related]
12. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.
Molenaar P; Chen L; Semmler AB; Parsonage WA; Kaumann AJ
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1020-8. PubMed ID: 17714089
[TBL] [Abstract][Full Text] [Related]
13. Enhanced inhibition of L-type Ca2+ current by beta3-adrenergic stimulation in failing rat heart.
Zhang ZS; Cheng HJ; Onishi K; Ohte N; Wannenburg T; Cheng CP
J Pharmacol Exp Ther; 2005 Dec; 315(3):1203-11. PubMed ID: 16135702
[TBL] [Abstract][Full Text] [Related]
14. Physiological evidence for β3-adrenoceptor in frog (Rana esculenta) heart.
Mazza R; Angelone T; Pasqua T; Gattuso A
Gen Comp Endocrinol; 2010 Nov; 169(2):151-7. PubMed ID: 20709064
[TBL] [Abstract][Full Text] [Related]
15. In vivo beta3-adrenergic stimulation of human thermogenesis and lipid use.
Schiffelers SL; Blaak EE; Saris WH; van Baak MA
Clin Pharmacol Ther; 2000 May; 67(5):558-66. PubMed ID: 10824635
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of beta-adrenoceptor subtypes mediating relaxation in porcine isolated ureteral smooth muscle.
Wanajo I; Tomiyama Y; Yamazaki Y; Kojima M; Shibata N
J Urol; 2004 Sep; 172(3):1155-9. PubMed ID: 15311061
[TBL] [Abstract][Full Text] [Related]
17. β3-Adrenoceptor-mediated responses in diabetic rat heart.
Kayki-Mutlu G; Arioglu-Inan E; Ozakca I; Ozcelikay AT; Altan VM
Gen Physiol Biophys; 2014; 33(1):99-109. PubMed ID: 24334532
[TBL] [Abstract][Full Text] [Related]
18. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors.
Molenaar P; Sarsero D; Arch JR; Kelly J; Henson SM; Kaumann AJ
Br J Pharmacol; 1997 Jan; 120(2):165-76. PubMed ID: 9117106
[TBL] [Abstract][Full Text] [Related]
19. Species differences in the distribution of beta-adrenoceptor subtypes in bladder smooth muscle.
Yamazaki Y; Takeda H; Akahane M; Igawa Y; Nishizawa O; Ajisawa Y
Br J Pharmacol; 1998 Jun; 124(3):593-9. PubMed ID: 9647486
[TBL] [Abstract][Full Text] [Related]
20. Rabbit, a relevant model for the study of cardiac beta 3-adrenoceptors.
Audigane L; Kerfant BG; El Harchi A; Lorenzen-Schmidt I; Toumaniantz G; Cantereau A; Potreau D; Charpentier F; Noireaud J; Gauthier C
Exp Physiol; 2009 Apr; 94(4):400-11. PubMed ID: 19151075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
